BrightSpring Health Services, Inc. - Common Stock (BTSG)
26.45
-1.54 (-5.50%)
NASDAQ · Last Trade: Sep 12th, 9:44 PM EDT
Detailed Quote
Previous Close
27.99
Open
27.75
Bid
26.02
Ask
26.85
Day's Range
26.19 - 28.24
52 Week Range
13.40 - 28.43
Volume
4,264,456
Market Cap
-
PE Ratio (TTM)
-
EPS (TTM)
-
Dividend & Yield
N/A (N/A)
1 Month Average Volume
2,742,931
Chart
About BrightSpring Health Services, Inc. - Common Stock (BTSG)
BrightSpring Health Services, Inc. is a leading provider of comprehensive health services that cater to the needs of individuals requiring specialized care, including those with complex health challenges. The company offers a wide range of services, such as home health care, hospice care, and rehabilitation services, aimed at enhancing the quality of life for patients while supporting their families. By employing innovative care solutions and integrating advanced technologies, BrightSpring focuses on delivering patient-centered approaches that promote independence and well-being within the comfort of their own homes or community settings. With a commitment to exceptional care and service delivery, BrightSpring Health Services plays a crucial role in the healthcare ecosystem, serving vulnerable populations and improving health outcomes. Read More
Market swings can be tough to stomach, and volatile stocks often experience exaggerated moves in both directions.
While many thrive during risk-on environments, many also struggle to maintain investor confidence when the ride gets bumpy.
As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the senior health, home health & hospice industry, including BrightSpring Health Services (NASDAQ:BTSG) and its peers.
BrightSpring Health Services (BTSG) shows strong high-growth momentum with 130% EPS growth and a top technical rating, forming a bull flag pattern for a potential breakout.
Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names.
But with less stability and fewer resources than their bigger counterparts, these companies face steeper challenges in scaling their businesses.
Healthcare services provider BrightSpring Health Services (NASDAQ:BTSG) reported Q2 CY2025 results exceeding the market’s revenue expectations, with sales up 29.1% year on year to $3.15 billion. The company expects the full year’s revenue to be around $12.4 billion, close to analysts’ estimates. Its non-GAAP profit of $0.22 per share was 18.6% above analysts’ consensus estimates.
A number of stocks jumped in the afternoon session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. The latest Consumer Price Index (CPI) report showed inflation rose by a modest 0.2% in July and 2.7% over the last year. This cooler-than-expected data prompted a significant market rally, with the S&P 500, Dow, and Nasdaq all climbing as investors grew more optimistic. The prevailing view is that easing inflation gives the central bank room to lower interest rates. Lower rates typically reduce borrowing costs for businesses and make stocks more attractive relative to bonds, contributing to widespread gains across sectors like healthcare.
Growth boosts valuation multiples, but it doesn’t always last forever.
Companies that cannot maintain it are often penalized with large declines in market value, a lesson ingrained in investors who lost money in tech stocks during 2022.
Healthcare services provider BrightSpring Health Services (NASDAQ:BTSG) reported Q2 CY2025 results exceeding the market’s revenue expectations, with sales up 15.3% year on year to $3.15 billion. The company expects the full year’s revenue to be around $12.4 billion, close to analysts’ estimates. Its non-GAAP profit of $0.22 per share was 17.6% above analysts’ consensus estimates.
LOUISVILLE, Ky., Aug. 01, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG), a leading provider of home and community-based health services for complex populations, today announced financial results for the second quarter ended June 30, 2025, and increased Revenue and Adjusted EBITDA1 guidance.
Generating cash is essential for any business, but not all cash-rich companies are great investments.
Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
LOUISVILLE, Ky., July 08, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today that it plans to release its second quarter 2025 financial results on Friday, August 1, 2025, prior to the Company’s earnings conference call, which will be held at 8:30 a.m. ET on the same day.
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destockings have persisted in the wake of COVID-19,
and over the past six months, the industry has pulled back by 6.6%. This drop was disheartening since the S&P 500 held its ground.
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings.
However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.
Stocks that outperform the market usually share key traits such as rising sales, expanding margins, and increasing returns on capital.
The select few that can do all three for many years are often the ones that make you life-changing money.
LOUISVILLE, Ky., June 18, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services (“BrightSpring” or “BrightSpring Health Services”) (NASDAQ: BTSG) is proud to announce that its specialty pharmacy, Onco360®, has been selected as the national pharmacy partner for several newly approved therapies in the treatment of advanced cancers and rare genetic disorders.
Growth is oxygen.
But when it evaporates, the consequences can be extreme - ask anyone who bought Cisco in the Dot-Com Bubble (Nvidia?) or newer investors who lived through the 2020 to 2022 COVID cycle.
